PRL and breast cancer: A preclinical study demonstrated that prolactin could suppress cellular growth or metastasis of breast cancer [14], and another study indicated that the 16-kDa prolactin isoform, a prolactin fragment, had anti-angiogenic effects in in vivo experiments [49].